Median Technologies is a leading brand that helps life sciences companies transform data into life-changing therapies. They offer unprecedented clinical trial imaging insights and expertise to improve business and patient outcomes. They specialize in transforming medical images into meaningful, actionable insights to better diagnose, treat, and monitor patients.

Utilizing proprietary artificial intelligence, computer vision, and signal processing technologies, they develop imaging tests and services that address life-threatening unmet medical needs. One of their groundbreaking developments is iBiopsy®, a technology that disrupts the management of serious diseases such as lung cancer, liver cancer, and NASH. By deploying AI/ML Software as Medical Devices, they assist health professionals in diagnosing patients earlier, treating them more effectively, and bringing new hope.

Median Technologies is recognized for their expertise in medical image management, generating AI-driven actionable data for oncology drug development, and providing accurate AI-driven diagnosis. They also develop non-invasive, early-stage diagnostic solutions for routine clinical use and broader screening programs. As a game changer in the medical space, they leverage their clinical expertise, proprietary technologies, and data science experience to generate unprecedented insights from medical images for both drug development and patient care